Catalyst Pharmaceuticals (CPRX) Non-Current Assets (2010 - 2026)
Catalyst Pharmaceuticals posted quarterly Non-Current Assets of $207.2 million for Q1 2026, down 7.14% year-on-year from $223.2 million in Q1 2025, and down 1.3% on a QoQ basis from $209.9 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 17 years of Non-Current Assets data on file, last reported at $207.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 7.14% year-over-year to $207.2 million; the trailing twelve-month figure through Mar 2026 stood at $829.5 million (down 9.43% YoY), and the FY2025 full-year result was $209.9 million, down 7.84% from the prior year.
- Non-Current Assets for Q1 2026 stood at $207.2 million, down from $209.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $250.8 million in Q4 2023 and bottomed at $24.8 million in Q2 2022.
- The 5-year median for Non-Current Assets is $209.9 million (2025), against an average of $178.4 million.
- The widest annual swing landed in 2022, when Non-Current Assets fell 27.75%; it then jumped 719.88% in 2023.
- A 5-year view of Non-Current Assets shows it stood at $54.8 million in 2022, then surged by 357.44% to $250.8 million in 2023, then declined by 9.16% to $227.8 million in 2024, then retreated by 7.84% to $209.9 million in 2025, then retreated by 1.3% to $207.2 million in 2026.
- The last three Non-Current Assets figures came in at $207.2 million (Q1 2026), $209.9 million (Q4 2025), and $199.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 207.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 207.22 Mn |
| Dec 31, 2025 | 209.95 Mn |
| Sep 30, 2025 | 199.15 Mn |
| Jun 30, 2025 | 213.18 Mn |
| Mar 31, 2025 | 223.15 Mn |
| Dec 31, 2024 | 227.80 Mn |
| Sep 30, 2024 | 233.01 Mn |
| Jun 30, 2024 | 231.93 Mn |
| Mar 31, 2024 | 242.07 Mn |
| Dec 31, 2023 | 250.79 Mn |
| Sep 30, 2023 | 221.19 Mn |
| Jun 30, 2023 | 202.93 Mn |
| Mar 31, 2023 | 208.32 Mn |
| Dec 31, 2022 | 54.82 Mn |
| Sep 30, 2022 | 56.80 Mn |
| Jun 30, 2022 | 24.75 Mn |
| Mar 31, 2022 | 25.78 Mn |
| Dec 31, 2021 | 27.68 Mn |
| Sep 30, 2021 | 30.45 Mn |
| Jun 30, 2021 | 32.83 Mn |
| Mar 31, 2021 | 35.68 Mn |
| Dec 31, 2020 | 33.11 Mn |
| Sep 30, 2020 | 31.52 Mn |
| Jun 30, 2020 | 248,113.00 |
| Mar 31, 2020 | 936,098.00 |
| Dec 31, 2019 | 1.01 Mn |
| Sep 30, 2019 | 6.11 Mn |
| Jun 30, 2019 | 6.18 Mn |
| Mar 31, 2019 | 6.21 Mn |
| Dec 31, 2018 | 5.26 Mn |
| Sep 30, 2018 | 5.23 Mn |
| Jun 30, 2018 | 5.20 Mn |
| Mar 31, 2018 | 192,258.00 |
| Dec 31, 2017 | 200,273.00 |
| Sep 30, 2017 | 214,338.00 |
| Jun 30, 2017 | 227,177.00 |
| Mar 31, 2017 | 240,134.00 |
| Dec 31, 2016 | 253,092.00 |
| Sep 30, 2016 | 257,926.00 |
| Jun 30, 2016 | 267,406.00 |
| Mar 31, 2016 | 187,239.00 |
| Dec 31, 2015 | 200,437.00 |
| Sep 30, 2015 | 206,523.00 |
| Jun 30, 2015 | 72,182.00 |
| Mar 31, 2015 | 80,027.00 |
| Dec 31, 2014 | 80,265.00 |
| Sep 30, 2014 | 80,168.00 |
| Jun 30, 2014 | 74,284.00 |
| Mar 31, 2014 | 61,537.00 |
| Dec 31, 2013 | 49,516.00 |
| Sep 30, 2013 | 55,222.00 |
| Jun 30, 2013 | 60,929.00 |
| Dec 31, 2012 | 62,567.00 |
| Mar 31, 2012 | 23,254.00 |
| Dec 31, 2011 | 21,074.00 |
| Sep 30, 2011 | 28,792.00 |
| Jun 30, 2011 | 36,244.00 |
| Dec 31, 2010 | 56,084.00 |